[ad_1] Immunotherapy with pembrolizumab improves survival in patients with recurrent or metastasized, according to late-breaking results from the KEYNOTE-048 study reported at ESMO 2018 Congress in Munich. The current standard treatment for …
Read More »Researchers Investigate New Effective Treatment Against Recurrent Breast Cancers
[ad_1] July 30, 2018 What does one in five breast cancer have in common? Large amounts of a protein called HER2 (or human epidermal growth factor 2 receptor). "Every healthy cell produces …
Read More »